ライフサイエンスコーパス: operative treatment

1 uld be at least 3-6 months before opting for operative treatment.

2 out reducing the rates of late detection and operative treatment.

3 Models were adjusted for age, sex, and operative treatment.

4 a high recurrence risk despite pre- and post-operative treatment.

5 ion, strong consideration should be given to operative treatment.

6 minimize complication rates associated with operative treatments.

7 joint pathologies and to guide refinement of operative treatments.

8 Of the 190 patients who underwent operative treatment, 160 patients (84.2%) had a TLICS sc

9 In regard to the peri-operative treatments administrated to patients, our stud

10 ge on the safe and effective outcomes of non-operative treatment alternatives has further underlined

11 h-related quality of life for antibiotic and operative treatment, and to ascertain costs in a cohort.

12 with radiation; colonoscopy at 3 years after operative treatment, and, if results are normal, every 5

13 current standard of care for burns requiring operative treatment consists of early burn excision and

14 , making it a better candidate for potential operative treatment during pregnancy than MIL alone.

15 ollow-up PCP visit, 108 544 (31.4%) received operative treatment during their index admission, and 23

16 ications for chromophores in diagnostics and operative treatment exploit unique chemical structures s

17 ized clinical trial reveal that, on average, operative treatment for ASLS provided significantly grea

18 c osteosynthesis plates for patients needing operative treatment for displaced associated-type acetab

19 The effectiveness of operative treatment for midcarpal instability and distal

20 2005) identified 183 patients who underwent operative treatment for PENs.

21 ransmyocardial revascularisation (TMR) is an operative treatment for refractory angina pectoris when

22 sting literature provides little guidance to operative treatment for the wide spectrum of hand derang

23 tients were classified into conservative and operative treatment groups.

24 ts with Achilles tendon rupture who have non-operative treatment have traditionally been treated with

25 iotherapy versus radiotherapy alone as a pre-operative treatment in patients with locally advanced so

26 of HER3-DXd during short-term (21 days) pre-operative treatment in patients with primary operable HE

27 ection, early treatment, late detection, and operative treatment incidences.

28 In the absence of peritonitis, operative treatment is associated with increased morbidi

29 Although non-operative treatment is regarded as the first-line respon

30 ment, but there are a few circumstances when operative treatment may be required.

31 ss research study suggest that risk-adjusted operative treatment of acute cholecystitis in older pati

32 interval appendicectomy after successful non-operative treatment of an appendix mass in children.

33 during early follow-up after successful non-operative treatment of an appendix mass.

34 hin 1 year of enrolment after successful non-operative treatment of appendix mass (active observation

35 Operative treatment of biliary stricture was more likely

36 isolated from temporal tissue removed during operative treatment of epilepsy.

37 Operative treatment of higher degree acromioclavicular j

38 ent selection is of vital importance for the operative treatment of pancreatic cancer (pancreatic duc

39 The operative treatment of pediatric tibia fractures has und

40 idity and mortality between nonoperative and operative treatment of pneumoperitoneum.

41 Cost data showed that operative treatment of simple bowel obstruction increase

42 all patients in the sestamibi arm underwent operative treatment of their hyperparathyroidism.

43 option with better cost-utility compared to operative treatment options in uncomplicated acute appen

44 Time required to discuss non-operative treatments or the consulting intensivists' end

45 plus opioids (OR, 1.84; 95% CI, 1.73-1.95), operative treatment (OR, 1.78; 95% CI, 1.69-1.86), open

46 recision of a clinician when it comes to pre-operative treatment planning.

47 This operative treatment provided clinical benefits in patien

48 The late detection and operative treatment rates with universal screening were

49 o the use of anti-EGFR treatments, in a peri-operative treatment schedule, aimed to timely treat BC p

50 In addition, advances in operative and non-operative treatment strategies may provide more effectiv

51 Functional bracing is an alternative non-operative treatment that allows earlier mobilisation, bu

52 atients (52%) in the CT group have undergone operative treatment to date, whereas all patients in the

53 age were key determinants of treatment, with operative treatment used for diffuse GJ leaks, bilious d

54 Among all patients, operative treatment was associated with a lower risk of

55 operative and nonoperative treatment groups; operative treatment was associated with a lower risk of

56 ith neurosurgery at any time, maintained non-operative treatment was associated with adjusted hazard

57 Using logistic regression, operative treatment was associated with increased depend

58 Among patients with clinical peritonitis, operative treatment was associated with reduced mortalit

59 The risk-adjusted cost of operative treatment was higher at the index hospitalizat

60 Whether operative treatment was provided during the admission wa

61 The corresponding incidences of operative treatment were 0.2 (95% CI, 0.0-0.9) operation

62 ics showed improved cost savings compared to operative treatments with an ICER of -113,973.09 USD per

63 Our hypothesis was that operative treatment would be associated with decreased m